<i>KCNJ11</i> readthrough variant in a patient with congenital hyperinsulinism
<i>KCNJ11</i> is one of the major causative genes for congenital hyperinsulinism (CHI) characterized by neonatal and infantile hypoglycemia. Although one readthrough <i>KCNJ11</i> variant has been identified in a patient with CHI, the pathogenicity of the substitution has yet to be confirmed. Here, we identified two heterozygous nucleotide substitutions separated by one nucleotide (c.[1170C>T;1172G>T], alternative description, c.1170_1172delinsTTT) in one allele of <i>KCNJ11</i> in a neonate with CHI and his father with mild CHI-compatible features. The c.1170C>T and c.1172G>T variants were assumed to be silent p.(Ser390Ser) and readthrough p.(Ter391LeuextTer93) substitutions, respectively. These results suggest that a mutant KCNJ11 protein containing 93 additional amino acids at the C-terminus is likely to exert dominant-negative effects on the wildtype protein and that monoallelic <i>KCNJ11</i> readthrough variants constitute a rare etiology of CHI.
Authors
- Keiichi Sugihara
- Ikuko Kageyama
- Erika Uehara (ORCID: https://orcid.org/0000-0001-8248-1845)
- Keiko Matsubara (ORCID: https://orcid.org/0000-0001-6254-9216)
- Maki Fukami (ORCID: https://orcid.org/0000-0001-9971-4035)
- Ikue Hata (ORCID: https://orcid.org/0000-0001-6970-440X)
- Kazuhisa Akiba (ORCID: https://orcid.org/0000-0003-3561-2552)
- Atsushi Hattori
Institutions
- Tohoku University (JP)
- Fukui Prefectural Hospital (JP)
- National Center For Child Health and Development (JP)
Publication Details
- Journal
- Clinical Pediatric Endocrinology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1297/cpe.2025-0025
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Center for Child Health and Development